Materiały źródłowe

• #1 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  There is currently no cure for Crohn’s disease, and there is no single treatment that works for everyone. However, there are several medicines that have been approved for treatment of Crohn’s disease. One goal of medical treatment is to reduce the inflammation that triggers symptoms. Another goal is to improve long-term prognosis by limiting complications. In the best cases, this may lead not only to symptom relief but also to long-term remission. […] Anti-inflammatory medicines are often the first step in the treatment of inflammatory bowel disease. They include: […] Corticosteroids such as prednisone and budesonide (Entocort EC) can help reduce inflammation in the body, but they don’t work for everyone with Crohn’s disease. […] These drugs also reduce inflammation, but they target your immune system, which produces the substances that cause inflammation. For some people, a combination of these drugs works better than one drug alone.

• #2 Treatment for Crohn’s Disease – NIDDK

  https://www.niddk.nih.gov/health-information/digestive-diseases/crohns-disease/treatment

  Doctors treat Crohns disease with medicines and surgery. […] The goals of treatment are to lower inflammation in your intestines, prevent flares of your symptoms, and keep you in remission. […] Many people with Crohns disease need medicines. […] Medicines do not cure Crohns disease. However, medicines can reduce inflammation and bring on and maintain remissiona time when your symptoms disappear. […] Even with medicines, many people will need surgery to treat their Crohns disease. […] Surgery will not cure Crohns disease. However, it can treat complications and improve symptoms. […] A doctor may also recommend surgery if medicines do not improve your symptoms. […] Doctors may recommend or prescribe other ways to treat symptoms or complications of Crohns disease. […] Doctors most often treat severe complications in a hospital.

• #3 Diagnosis and Management of Crohn’s Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2011/1215/p1365.html

  Mesalamine products are often used for the medical management of mild to moderate colonic Crohn’s disease. […] Antibiotics (e.g., metronidazole, fluoroquinolones) are often used for treatment. […] Patients with moderate to severe Crohn’s disease are treated with corticosteroids, azathioprine, 6-mercaptopurine, or antitumor necrosis factor agents (e.g., infliximab, adalimumab). […] Budesonide (Entocort EC) is effective in inducing, but not maintaining, remission in patients with Crohn’s disease. […] Corticosteroids are more effective than placebo and 5-aminosalicylic acid products in inducing remission in patients with Crohn’s disease. […] Azathioprine (Imuran) and 6-mercaptopurine are effective in inducing remission in patients with active Crohn’s disease. […] Methotrexate is effective in inducing and maintaining remission in patients with Crohn’s disease.

• #4 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Medications for Crohn’s disease are mainly used to reduce inflammation. […] The main types include: […] Aminosalicylates (5-ASAs): Used to reduce inflammation in the lining of the gut. […] Corticosteroids (steroids): Usually used to treat moderate-to-severe Crohn’s disease they block the body’s inflammatory response. […] Immunosuppressants: Used to suppress the body’s immune response which decreases inflammation. […] Biologics: These are a newer class of drugs for Crohn’s disease that are specially made antibodies, which selectively bind to inflammatory signaling proteins to reduce inflammation. […] Antibiotics: Used in Crohn’s disease to treat abscesses or fistulas, and after some types of surgery. […] Diet has an important role to play in of many aspects of Crohn’s disease, including treating active disease, managing symptoms, ensuring nutritional adequacy and often complications of Crohn’s disease.

• #5 Management of Crohn Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC9183209/

  A systematic review that included 20 randomized clinical trials that evaluated the efficacy of aminosalicylates in mild to moderate Crohn disease found that high-dose mesalamine was not superior to placebo in induction of remission. […] As described above, combination therapy (anti-TNF and thiopurine) is an effective management strategy for moderate to severe Crohn disease. […] The management of Crohn disease requires close monitoring of inflammation and careful assessment and adjustment of medical therapy to achieve clinical and endoscopic remission. […] When a patient has a flare of symptoms, it is important to assess for infection because Escherichia coli, Norovirus, and Clostridioides difficile are all common causes of changes in symptoms that resemble Crohn disease flares. […] Mild to moderate flares can often be managed with the gut-selective steroid budesonide, which has fewer adverse effects than systemic corticosteroids.

• #6 Management of Crohn’s disease – Wikipedia

  https://en.wikipedia.org/wiki/Management_of_Crohn%27s_disease

  Current guidelines do not advise the use of 5-ASA compounds in Crohn’s disease. […] Corticosteroids are a class of anti-inflammatory drugs used to treat moderate to severe flares of Crohn’s disease. However, they are used sparingly because they can cause serious side effects, including Cushing’s syndrome, mania, insomnia, hypertension, high blood glucose, osteoporosis, and avascular necrosis of long bones. […] The most commonly prescribed oral steroid is prednisone, which is typically dosed at 0.5 mg/kg for induction of remission in Crohn’s disease. […] Azathioprine and 6-mercaptopurine (6-MP) are the most commonly used immunosuppressants for maintenance therapy of Crohn’s disease. […] A Cochrane systematic review that included 13 randomized controlled trials concluded that azathioprine and 6-mercaptopurine are not effective for inducing remission when a person has Crohn’s disease.

• #7 Diagnosis and Management of Crohn’s Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2011/1215/p1365.html

  Azathioprine and 6-mercaptopurine can effectively induce remission in patients with active Crohn’s disease within three to six months of achieving the maximal dose. […] Methotrexate is an alternative therapy for patients intolerant of azathioprine or 6-mercaptopurine. […] Anti-TNF therapy has been shown to effectively induce and maintain remission in patients with moderate to severe Crohn’s disease. […] Azathioprine is effective for maintenance of remission in patients with Crohn’s disease. […] Increasing evidence supports that top-down therapy beginning with infliximab and azathioprine may offer corticosteroid-sparing benefits for corticosteroid-naive patients. […] Evidence demonstrates that low-dose conventional corticosteroids and 5-ASA preparations are ineffective in maintaining remission in patients with Crohn’s disease. […] The most common indications for surgery include refractory disease, intractable hemorrhage, perforation, obstruction, abscess, dysplasia, cancer, and unresponsive fulminant disease.

• #8 Diagnosis and Management of Crohn’s Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2011/1215/p1365.html

  Mesalamine products are often used for the medical management of mild to moderate colonic Crohn’s disease. […] Antibiotics (e.g., metronidazole, fluoroquinolones) are often used for treatment. […] Patients with moderate to severe Crohn’s disease are treated with corticosteroids, azathioprine, 6-mercaptopurine, or antitumor necrosis factor agents (e.g., infliximab, adalimumab). […] Budesonide (Entocort EC) is effective in inducing, but not maintaining, remission in patients with Crohn’s disease. […] Corticosteroids are more effective than placebo and 5-aminosalicylic acid products in inducing remission in patients with Crohn’s disease. […] Azathioprine (Imuran) and 6-mercaptopurine are effective in inducing remission in patients with active Crohn’s disease. […] Methotrexate is effective in inducing and maintaining remission in patients with Crohn’s disease.

• #9 Crohn Disease Treatment & Management: Approach Considerations, Pharmacologic Therapy for Diarrhea, Anti-inflammatory and Immunosuppressant Therapy for Active Crohn Disease

  https://emedicine.medscape.com/article/172940-treatment

  Enteric-coated ileal-release preparations with decreased systemic effects (eg, budesonide) have been developed to treat ileal and cecal Crohn disease. […] If steroid withdrawal proves difficult, immunosuppressants such as azathioprine or its active metabolite 6-MP may be considered. […] Methotrexate is effective in inducing and maintaining remission in Crohn disease in adults; it has also been shown to be effective and well tolerated for maintenance of remission in children. […] A systemic review of the efficacy of biologic therapies in IBD confirmed that placebo is inferior to antiTNF- antibodies and natalizumab in inducing remission of active Crohn disease. […] Patients who have moderate to severe debilitating symptoms of Crohn disease, who have documented active inflammation, or who are dependent on corticosteroids and unable to taper these agents without return of symptoms

• #10 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #11

  https://journals.lww.com/ajg/fulltext/2018/04000/acg_clinical_guideline__management_of_crohn_s.10.aspx

  Symptoms of Crohn’s disease do not correlate well with the presence of active inflammation, and therefore should not be the sole guide for therapy. Objective evaluation by endoscopic or cross-sectional imaging should be undertaken periodically to avoid errors of under- or overtreatment. […] The 10-year cumulative risk of major abdominal surgery in Crohn’s disease is 40% to 55%, although recent studies performed in the biologic era suggest that the 10-year risk may have decreased to 30%. […] In Crohn’s disease, the 5-year rate of symptomatic post-operative recurrence is 50%. […] Anti-TNF agents (infliximab, adalimumab, certolizumab pegol) should be used to treat Crohn’s disease that is resistant to treatment with corticosteroids. […] Anti-TNF agents should be given for Crohn’s disease refractory to thiopurines or methotrexate.

• #12 Management of Crohn’s disease – Wikipedia

  https://en.wikipedia.org/wiki/Management_of_Crohn%27s_disease

  Azathioprine and 6-MP may be useful for the following indications: Maintenance therapy with azathioprine or 6-mercaptopurine may lead people with active Crohn’s to take less steroid medication. This may lower side effects related to steroid treatments. […] Infliximab has found utility as follows: Induction and maintenance of remission for people with Crohn’s disease. […] Adalimumab has been shown to reduce the signs and symptoms of, and is approved for treatment of, moderate to severe Crohn’s disease in adults who have not responded well to conventional treatments and who have lost response to or are unable to tolerate infliximab. […] Natalizumab may be appropriate in patients who do not respond to medications that block tumor necrosis factor-alpha, such as infliximab. […] Ustekinumab was approved by the FDA for the treatment of Crohn’s disease in 2016. Evidence from four quality randomized control trials suggest that ustekinumab is effective for induction of clinical remission and clinical improvement in patients with moderate to severe Crohn’s disease.

• #13 Crohn’s Disease Treatment Options – RINVOQ® (upadacitinib)

  https://www.rinvoq.com/crohns-disease/about-crohns/crohns-treatment-options

  HUMIRA is a prescription medicine used to treat moderate to severe Crohns disease (CD) in adults and children 6 years of age and older. […] REMICADE is a prescription medication for adults living with moderately to severely active Crohns disease who haven’t responded well to other medicines. […] SKYRIZI is a prescription medicine used to treat moderate to severe Crohns disease in adults. […] STELARA is a prescription medicine used to treat adults 18 years and older with moderately to severely active Crohns disease. […] ENTYVIO is a prescription medicine used in adults for the treatment of moderately to severely active Crohns disease. […] Talk to your doctor about the risks and benefits of your treatment options. These medications should be used under the supervision of a healthcare professional. Always tell your doctor about any side effects you may be experiencing. […] Deciding to change your treatment plan is never easy, but neither is living with Crohns symptoms.

• #14

  https://journals.lww.com/ajg/fulltext/2018/04000/acg_clinical_guideline__management_of_crohn_s.10.aspx

  Combination therapy of infliximab with immunomodulators (thiopurines) is more effective than treatment with either immunomodulators alone or infliximab alone in patients who are naive to those agents. […] Ustekinumab should be given for moderate-to-severe Crohn’s disease patients who have failed previous treatment with corticosteroids, thiopurines, methotrexate, or anti-TNF inhibitors, or who have had no prior exposure to anti-TNF inhibitors. […] Vedolizumab should be used for maintenance of remission of vedolizumab-induced remission of Crohn’s disease. […] Thiopurines may be used to prevent clinical and endoscopic recurrence and are more effective than mesalamine or placebo. However, they are not effective at preventing severe endoscopic recurrence. […] Anti-TNF therapy, specifically infliximab, adalimumab, and certolizumab pegol, should be used to maintain remission of anti-TNF-induced remission. […] The presence of a perianal abscess in CD should prompt surgical drainage. […] Fistulizing CD is a therapeutic challenge that requires careful evaluation and coordination of care between medical and surgical providers in order to direct therapy appropriately.

• #15 Crohn’s Disease Treatment Options – RINVOQ® (upadacitinib)

  https://www.rinvoq.com/crohns-disease/about-crohns/crohns-treatment-options

  HUMIRA is a prescription medicine used to treat moderate to severe Crohns disease (CD) in adults and children 6 years of age and older. […] REMICADE is a prescription medication for adults living with moderately to severely active Crohns disease who haven’t responded well to other medicines. […] SKYRIZI is a prescription medicine used to treat moderate to severe Crohns disease in adults. […] STELARA is a prescription medicine used to treat adults 18 years and older with moderately to severely active Crohns disease. […] ENTYVIO is a prescription medicine used in adults for the treatment of moderately to severely active Crohns disease. […] Talk to your doctor about the risks and benefits of your treatment options. These medications should be used under the supervision of a healthcare professional. Always tell your doctor about any side effects you may be experiencing. […] Deciding to change your treatment plan is never easy, but neither is living with Crohns symptoms.

• #16

  https://journals.lww.com/ajg/fulltext/2018/04000/acg_clinical_guideline__management_of_crohn_s.10.aspx

  Combination therapy of infliximab with immunomodulators (thiopurines) is more effective than treatment with either immunomodulators alone or infliximab alone in patients who are naive to those agents. […] Ustekinumab should be given for moderate-to-severe Crohn’s disease patients who have failed previous treatment with corticosteroids, thiopurines, methotrexate, or anti-TNF inhibitors, or who have had no prior exposure to anti-TNF inhibitors. […] Vedolizumab should be used for maintenance of remission of vedolizumab-induced remission of Crohn’s disease. […] Thiopurines may be used to prevent clinical and endoscopic recurrence and are more effective than mesalamine or placebo. However, they are not effective at preventing severe endoscopic recurrence. […] Anti-TNF therapy, specifically infliximab, adalimumab, and certolizumab pegol, should be used to maintain remission of anti-TNF-induced remission. […] The presence of a perianal abscess in CD should prompt surgical drainage. […] Fistulizing CD is a therapeutic challenge that requires careful evaluation and coordination of care between medical and surgical providers in order to direct therapy appropriately.

• #17 Crohn Disease Treatment & Management: Approach Considerations, Pharmacologic Therapy for Diarrhea, Anti-inflammatory and Immunosuppressant Therapy for Active Crohn Disease

  https://emedicine.medscape.com/article/172940-treatment

  In January 2025, the FDA approved mirikizumab, an IL23P19 antagonist, for moderately to severe adult Crohn disease. Studies have shown that mirikizumab improves symptoms as well as induces and maintains remission in moderately to severe active CD. […] Nutritional therapy is another important modality for the treatment of disease, malnutrition, and growth failure in Crohn disease. […] Both parenteral and enteral nutrition are effective. Additionally, exclusive enteral nutrition (EEN) has been shown to be as effective as corticosteroids for the induction of remission and might promote better gastrointestinal (GI) tract mucosal healing. […] Surgical intervention plays an integral role in controlling the symptoms and treating the complications of Crohn disease, but operative resection is not curative.

• #18 Crohn’s Disease Treatment: Medication, Surgery, and More

  https://www.everydayhealth.com/crohns-disease/guide/treatment/

  In January 2025, a new biologic, mirikizumab (Omvoh), was approved by the U.S. Food and Drug Administration (FDA) to treat Crohns. […] Your doctor may recommend surgery if your symptoms aren’t getting better with medicine. Surgery isn’t a cure for Crohn’s disease, but some people experience relief from symptoms for many years after surgery. […] Along with standard treatments, certain lifestyle changes can help you manage your symptoms. […] It’s important to eat a well-balanced and nutritious diet if you have Crohns disease. Not only can eating the right foods help you feel better, but it can also help reduce symptoms. […] In some cases, a doctor may recommend nutrition therapy in the form of exclusive enteral nutrition (EEN) to help ease flare-ups. […] While stress does not cause Crohns disease, it can worsen symptoms and trigger flare-ups.

• #19 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #20 Crohn’s Disease Treatment Options – RINVOQ® (upadacitinib)

  https://www.rinvoq.com/crohns-disease/about-crohns/crohns-treatment-options

  Theres no one size fits all solution for treating Crohns disease. If your symptoms wont go away, it may be a sign that a change in treatment plan is needed. Be sure to discuss the risks and benefits of any treatment with your gastroenterologist. […] Some Crohns treatment options include: […] Conventional therapies […] Advanced therapies refer to biologics and oral small molecules. JAK inhibitors are an example of an advanced therapy that is prescribed after a TNF blocker. […] RINVOQ is used to treat adults with moderate to severe Crohns disease when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated. […] CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to lessen the signs and symptoms of moderately to severely active Crohns disease in adults who have not been helped enough by usual treatments.

• #21 RINVOQ® (upadacitinib) for Crohn’s Disease (CD)

  https://www.rinvoq.com/crohns-disease

  RINVOQ is a prescription medicine used to treat adults with moderate to severe Crohns disease when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated. […] RINVOQ is proven to deliver rapid symptom relief in as early as 2 weeks and lasting remission at 1 year. […] Talk to your gastro about treatment options that may be appropriate for you. […] Ask your doctor about treatment options that can help you achieve steroid-free remission.

• #22 Crohn’s Disease and Ulcerative Colitis Treatment

  https://www.froedtert.com/ibd-crohns-colitis/treatment

  Corticosteroids: These anti-inflammatory agents work quickly for IBD flares. We do not recommend long-term use of corticosteroids due to their side effects. […] Aminosalicylates (5-ASA): 5-ASAs affect parts of the inflammatory response, thereby decreasing tissue irritation. […] Immunomodulators: Azathioprine, leflunomide, mercaptopurine, tacrolimus, tofacitinib and methotrexate are some of the most common oral immunomodulators used for Crohns disease and ulcerative colitis. […] Biologics: Vedolizumab, ustekinumab, adalimumab, infliximab and natalizumab are monoclonal antibodies that bind to specific cells or proteins in the body to interfere with your bodys inflammatory pathway. […] You may need antibiotics for a variety of reasons during your Crohns disease or ulcerative colitis treatment to treat tissues injuries such as perianal disease and fistulas. […] Bulking agents (such as fiber) or drugs that increase muscle tone in the GI tract (such as loperamide) may reduce diarrhea. […] Your Crohns disease or ulcerative colitis may result in vitamin or mineral deficiencies.

• #23 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #24 Management of Crohn’s disease – Wikipedia

  https://en.wikipedia.org/wiki/Management_of_Crohn%27s_disease

  Surgery is normally reserved for complications of Crohn’s disease or when disease that resists treatment with drugs is confined to one location that can be removed. […] Many diets have been proposed for the management of Crohn’s disease, and many do improve symptoms, but none have been proven to cure the disease. […] The antibiotics Metronidazole and ciprofloxacin may be used to treat Crohn’s disease with colonic or perianal involvement, although this usage has not been approved by the Food and Drug Administration. […] Cannabis may be used to treat Crohn’s disease because of its anti-inflammatory properties. Cannabis and cannabis-derived drugs may also help to heal the gut lining, and may reduce the need for surgery and other medications.

• #25 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Medications for Crohn’s disease are mainly used to reduce inflammation. […] The main types include: […] Aminosalicylates (5-ASAs): Used to reduce inflammation in the lining of the gut. […] Corticosteroids (steroids): Usually used to treat moderate-to-severe Crohn’s disease they block the body’s inflammatory response. […] Immunosuppressants: Used to suppress the body’s immune response which decreases inflammation. […] Biologics: These are a newer class of drugs for Crohn’s disease that are specially made antibodies, which selectively bind to inflammatory signaling proteins to reduce inflammation. […] Antibiotics: Used in Crohn’s disease to treat abscesses or fistulas, and after some types of surgery. […] Diet has an important role to play in of many aspects of Crohn’s disease, including treating active disease, managing symptoms, ensuring nutritional adequacy and often complications of Crohn’s disease.

• #26 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Diet may also potentially support remission. […] There are dietary treatments that may be used to treat malnutrition, symptoms related to active inflammation, symptoms related to bowel sensitivity rather than inflammation and for certain complications of Crohn’s disease. […] Exclusive Enteral Nutrition (EEN): this diet is recommended first-line treatment for inducing remission in children with Crohn’s disease, but is also frequently used in adults. […] The goal of surgery is to keep as much of the bowel as possible while restoring quality of life. […] There are two main reasons why surgery may be an option for you. One, when current therapies are no longer effective and two, when complications like strictures develop. […] Surgery for Crohn’s disease is a treatment not everyone will need.

• #27 Managing Crohn’s Disease: Flare-Ups and Treatment Options

  https://www.hackensackmeridianhealth.org/en/healthu/2024/01/12/managing-crohns-disease-flare-ups-and-treatment-options

  People with Crohns disease periodically have flare-ups, with pain and frequent bowel movements. Fortunately, treatments are available that make flares easier to manage. […] Whenever you have a flare-up, its important to see your doctor, says gastroenterologist David Rosenheck, M.D. Theyll investigate its cause and provide appropriate treatments to help you go into remission. […] Different treatments are available to help manage Crohns disease flare-ups. The type of treatment that you receive depends upon your symptoms and personal circumstances. […] Doctors may recommend: Medication. During a flare-up, doctors may prescribe corticosteroids to reduce inflammation. Different medications reduce the activity of an overactive immune system, while others relieve symptoms. […] Bowel rest. Rarely, when a flare damages the intestines, they may need time to heal. Patients stop eating, except prescribed liquids, and receive nutrition intravenously or by feeding tube.

• #28 Managing Crohn’s Disease: Flare-Ups and Treatment Options

  https://www.hackensackmeridianhealth.org/en/healthu/2024/01/12/managing-crohns-disease-flare-ups-and-treatment-options

  Surgery. Sometimes, flare-ups lead to complications like intestinal bleeding, blockage or perforation. Surgery can correct problems like these. […] Doctors may also recommend lifestyle changes during a flare-up. They may suggest: Quitting smoking. Giving up cigarettes is a healthy choice for anyone, including people with Crohns disease. Smoking makes Crohns symptoms worse. […] Eating a healthy diet. There isnt a single diet thats right for everyone with Crohns disease. Doctors may recommend against certain foods or send you to a registered dietitian. […] However, many doctors recommend these eating habits when Crohns flares occur.

• #29 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #30 Crohn Disease Treatment & Management: Approach Considerations, Pharmacologic Therapy for Diarrhea, Anti-inflammatory and Immunosuppressant Therapy for Active Crohn Disease

  https://emedicine.medscape.com/article/172940-treatment

  Recommended indications for surgical intervention include the following: Persistent symptoms despite high-dose corticosteroid therapy […] Treatment-related complications, including intra-abdominal abscesses […] Medically intractable fistulae […] Fibrotic strictures with obstructive symptoms […] Toxic megacolon […] Intractable hemorrhage […] Perforation […] Cancer.

• #31 IBD, Ulcerative Colitis and Crohn’s Disease Treatment | Patient Care

  https://weillcornell.org/ulcerative-colitis-and-crohn-s-disease-surgery

  Strictureplasty: A stricture (a narrowed section of the intestine due to chronic/recurrent inflammation that causes the GI tract walls to thicken or form dense, stiff, scar tissue) can lead to narrowing of the intestine, intestinal blockage. This surgical procedure repairs the stricture by widening the narrowed section without removing any part of the intestine. […] Small and/or large bowel resection: This procedure removes the damaged portion of the digestive tract and reconnects the healthy bowel upstream and downstream. […] Colectomy: The colon (large bowel) is surgically removed. […] Proctocolectomy: The entire colon and rectum is removed. […] Fistula surgery: Fistulas develop when inflammation causes extension through the bowel wall, creating an abscess, or a collection of pus. These tracts may extend to neighboring structures. Fistula removal surgery may be necessary to remove the diseased segment of the intestine and separate it from the neighboring structures (which may or may not require resection of the secondarily involved structure).

• #32 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #33 Treatment of Crohn’s disease | UNC Multidisciplinary Inflammatory Bowel Diseases Center

  https://www.med.unc.edu/medicine/gi/ibd/treatment-of-ibd-1/treatment-of-crohns-disease/

  In most cases, these drugs successfully treat acute flare-ups of Crohns disease. […] The use of 5-aminosalicylic acid preparations has been shown to reduce the recurrence of the disease after surgery, though this effect is unfortunately far less pronounced following successful treatment with cortisone. […] Newer treatment methods, such as inhibition of tumor necrosis factor (TNF), a messenger substance in the body (e.g. infliximab or adalimumab), should only be tried if other therapeutical methods did not succeed or in patients with severe fistulizing disease. […] If these methods prove unsuccessful, or if complications such as intestinal obstruction or repeated stenoses occur, surgery may provide long-term relief. […] Surgery must also be considered for the treatment of fistulae. […] Following successful surgery, it is advisable to undergo regular follow-up conducted by experienced internists and surgeons working together.

• #34 Management of Crohn Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC9183209/

  A systematic review that included 20 randomized clinical trials that evaluated the efficacy of aminosalicylates in mild to moderate Crohn disease found that high-dose mesalamine was not superior to placebo in induction of remission. […] As described above, combination therapy (anti-TNF and thiopurine) is an effective management strategy for moderate to severe Crohn disease. […] The management of Crohn disease requires close monitoring of inflammation and careful assessment and adjustment of medical therapy to achieve clinical and endoscopic remission. […] When a patient has a flare of symptoms, it is important to assess for infection because Escherichia coli, Norovirus, and Clostridioides difficile are all common causes of changes in symptoms that resemble Crohn disease flares. […] Mild to moderate flares can often be managed with the gut-selective steroid budesonide, which has fewer adverse effects than systemic corticosteroids.

• #35

  https://journals.lww.com/ajg/fulltext/2018/04000/acg_clinical_guideline__management_of_crohn_s.10.aspx

  Combination therapy of infliximab with immunomodulators (thiopurines) is more effective than treatment with either immunomodulators alone or infliximab alone in patients who are naive to those agents. […] Ustekinumab should be given for moderate-to-severe Crohn’s disease patients who have failed previous treatment with corticosteroids, thiopurines, methotrexate, or anti-TNF inhibitors, or who have had no prior exposure to anti-TNF inhibitors. […] Vedolizumab should be used for maintenance of remission of vedolizumab-induced remission of Crohn’s disease. […] Thiopurines may be used to prevent clinical and endoscopic recurrence and are more effective than mesalamine or placebo. However, they are not effective at preventing severe endoscopic recurrence. […] Anti-TNF therapy, specifically infliximab, adalimumab, and certolizumab pegol, should be used to maintain remission of anti-TNF-induced remission. […] The presence of a perianal abscess in CD should prompt surgical drainage. […] Fistulizing CD is a therapeutic challenge that requires careful evaluation and coordination of care between medical and surgical providers in order to direct therapy appropriately.

• #36 Crohn Disease: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/172940-overview

  The general goals of treatment are as follows: To achieve the best possible clinical, laboratory, and histologic control of the inflammatory disease with the least adverse effects from medications […] To permit the patient to function as normally as possible […] In children, to promote growth with adequate nutrition; the unique problems encountered in the pediatric population necessitate a medical approach that promotes clinical improvement and reverses growth failure with minimal toxicity. […] Therapy is typically administered in a step-up approach, in which patients with mild disease are treated with 5-aminosalicylic acid (5-ASA), antibiotics, and nutritional therapy. If the patient does not respond to this approach or if the disease is more severe than was initially thought, corticosteroid and immunomodulatory therapy with 6-mercaptopurine (6-MP) or methotrexate is attempted. Finally, biologic and surgical therapies, at the tip of the treatment pyramid, are used.

• #37 Crohn Disease: Practice Essentials, Background, Pathophysiology

  https://emedicine.medscape.com/article/172940-overview

  A subpopulation of patients with risk factors for complicated disease and rapid progression may benefit from a top-down approach. This approach involves early and aggressive use of tumor necrosis factor (TNF) antagonists, which may alter the natural history of the disease, improve treatment response, and decrease the need for steroid therapy. […] Surgery plays an integral role in controlling medically refractory disease and treating complications of Crohn disease. Because of the high rate of disease recurrence after segmental bowel resection, the guiding principle of surgery is preservation of intestinal length and function.

• #38 Management of Crohn Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC9183209/

  Many patients want to discontinue their therapy after achieving remission because of concern for adverse effects or desire to limit medication use. However, medication discontinuation increases the risk of relapse, need for surgery, and risk of other disease-related complications. […] Most patients with Crohn disease will require intestinal surgery at some point in their life. A timely operation is important to prevent disease-related complications (eg, intra-abdominal abscesses, fistulae) and reduce postoperative complications. […] Therefore, anti-TNF therapy is an effective option for prevention of postoperative disease recurrence.

• #39 Management of Crohn’s disease – Wikipedia

  https://en.wikipedia.org/wiki/Management_of_Crohn%27s_disease

  Management of Crohn’s disease involves first treating the acute symptoms of the disease, then maintaining remission. Since Crohn’s disease is an immune system condition, it cannot be cured by medication or surgery. Treatment initially involves the use of medications to eliminate infections (generally antibiotics) and reduce inflammation (generally aminosalicylate anti-inflammatory drugs and corticosteroids). Surgery may be required for complications such as obstructions, fistulae, abscesses, or if the disease does not respond to drugs within a reasonable time. However, surgery cannot cure Crohn’s disease. It involves removing the diseased part of the intestine and rejoining the healthy ends, but the disease tends to recur after surgery. […] Once remission is induced, the goal of treatment becomes maintenance of remission: avoiding the return of active disease, or „flares”. Because of side effects, the prolonged use of corticosteroids is avoided. Although some people are able to maintain remission spontaneously, many require immunosuppressive drugs.

• #40 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Complementary and alternative medicine (CAM) for Crohn’s disease can be used alongside conventional treatment to reduce symptoms and improve wellbeing. […] Research is still ongoing in many areas of CAM so it is important to always talk about your options with your doctor. […] Probiotics: Research into how probiotics can help treat Crohn’s is still limited but taking them may help you stay in remission. […] Medical Cannabis: More research is needed before using medical cannabis to treat Crohn’s is recommended.

• #41 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Complementary and alternative medicine (CAM) for Crohn’s disease can be used alongside conventional treatment to reduce symptoms and improve wellbeing. […] Research is still ongoing in many areas of CAM so it is important to always talk about your options with your doctor. […] Probiotics: Research into how probiotics can help treat Crohn’s is still limited but taking them may help you stay in remission. […] Medical Cannabis: More research is needed before using medical cannabis to treat Crohn’s is recommended.

• #42 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  Complementary and alternative medicine (CAM) for Crohn’s disease can be used alongside conventional treatment to reduce symptoms and improve wellbeing. […] Research is still ongoing in many areas of CAM so it is important to always talk about your options with your doctor. […] Probiotics: Research into how probiotics can help treat Crohn’s is still limited but taking them may help you stay in remission. […] Medical Cannabis: More research is needed before using medical cannabis to treat Crohn’s is recommended.

• #43 Natural Treatments for Crohn’s Disease

  https://www.healthline.com/health/crohns-disease/alternative-treatments

  Acupuncture is an ancient practice that uses thin needles inserted into specific points on your body. […] There are some herbal and botanical treatments that may help ease the symptoms of Crohns disease. […] As always, its a good idea to talk with your doctor about any therapies youre considering. Some therapies may work well in conjunction with the medical treatments you currently use. Others may interact dangerously with your medical treatments.

• #44 Natural Treatments for Crohn’s Disease

  https://www.healthline.com/health/crohns-disease/alternative-treatments

  Acupuncture is an ancient practice that uses thin needles inserted into specific points on your body. […] There are some herbal and botanical treatments that may help ease the symptoms of Crohns disease. […] As always, its a good idea to talk with your doctor about any therapies youre considering. Some therapies may work well in conjunction with the medical treatments you currently use. Others may interact dangerously with your medical treatments.

• #45 Natural Treatments for Crohn’s Disease

  https://www.healthline.com/health/crohns-disease/alternative-treatments

  Acupuncture is an ancient practice that uses thin needles inserted into specific points on your body. […] There are some herbal and botanical treatments that may help ease the symptoms of Crohns disease. […] As always, its a good idea to talk with your doctor about any therapies youre considering. Some therapies may work well in conjunction with the medical treatments you currently use. Others may interact dangerously with your medical treatments.

• #46 Crohn’s Disease Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/crohns-disease-treatment/

  There are many ways to manage Crohn’s and what works for someone else may not work for you. Learning how to maximise your own wellbeing can be a long process but it’s worth it. […] The main goal of Crohn’s disease treatment is to reduce inflammation and symptoms. […] Research into Crohn’s disease has led to more treatment options in both medication and diet. […] In some cases Crohn’s disease complications may be treated with surgery. […] Crohn’s disease cannot currently be cured but for most people it can be well managed through medication, lifestyle choices and sometimes surgery. […] The aim of treatment is to reduce symptoms, control inflammation and heal the bowel. Since Crohn’s disease affects everyone differently, each person will need to work with their healthcare team to discover what works best for them. Treatment may also need to change over time if they become less effective.

• #47 Johnson & Johnson’s quest to develop effective IBD treatments

  https://www.jnj.com/innovation/inside-johnson-johnson-decades-long-quest-to-develop-effective-treatments-for-ibd

  Johnson Johnson developed another therapy that relieves IBD by stopping inflammation in the gut. […] Johnson Johnson researchers began investigating combination therapy, the use of two different medications at once, to improve IBD outcomes. […] Johnson Johnson launched a newly FDA-approved treatment for moderately to severely active UC, known as a dual-acting monoclonal antibody. […] The quest to find even more effective IBD treatments is ongoing. […] Company researchers are looking into even more groundbreaking treatment approaches. […] An exciting treatment possibility involves multispecific antibodies, which are engineered to bind to more than one protein at a time. […] We’re trying to raise the efficacy bar even higher for patients who would otherwise not have any other options or would still be suffering, even though they’re on the best therapy available.

• #48 Exploring the Newest Crohn’s Disease Medications (2025)

  https://www.dvcstem.com/post/new-crohns-medication

  Discover the latest advancements in Crohn’s disease treatment with an in-depth look at the five newest FDA-approved medications, transforming patient care and management. […] Crohn’s disease, a chronic inflammatory bowel disease, presents significant treatment challenges. The introduction of new medications offers renewed hope for patients seeking relief from its debilitating symptoms. […] The landscape of Crohn’s disease treatment is evolving, with a shift towards more targeted therapies that offer improved efficacy and reduced side effects. […] The introduction of Risankizumab-rzaa (Skyrizi) and Ustekinumab-auub (Wezlana) represents a significant milestone in Crohn’s disease treatment, offering new mechanisms of action with the potential for improved patient outcomes. […] Mesenchymal stem cell (MSC) therapy is gaining attention as a promising approach for treating Crohn’s disease, particularly for the management of complex perianal fistulas, which are often resistant to conventional treatments.

• #49 Crohn’s: How Close Is a Cure?

  https://www.webmd.com/ibd-crohns-disease/crohns-disease/features/crohns-cure

  Some of the treatments just around the corner include a new class of oral therapies. […] Researchers are also looking into how to manipulate the microbiome — that is, modify the balance of the intestines — to treat IBD. […] With so many advances on the horizon, the future of Crohns disease is very bright. But for now, I cant stress this enough: the vast majority of people with Crohns disease should be in remission and living unrestricted lives. […] If youre having symptoms, see a specialist so you can begin to look for a treatment plan that doesnt just control your symptoms but gets your disease under control, too, so that you can live your life.

• #50 Management of Crohn Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC9183209/

  Crohn disease, a chronic gastrointestinal inflammatory disease, is increasing in incidence and prevalence in many parts of the world. Therefore, early and effective control of inflammation is of critical importance. […] The optimal management approach for Crohn disease incorporates patient risk stratification, patient preference, and clinical factors in therapeutic decision-making. First-line therapy generally consists of steroids for rapid palliation of symptoms during initiation of antitumor necrosis factor therapy. Other treatments may include monoclonal antibodies to IL-12/23 or integrin 47, immunomodulators, combination therapies, or surgery. […] The treatment of patients with Crohn disease depends on disease severity, patient risk stratification, patient preference, and clinical factors, including age of onset and penetrating complications, and includes treatment with steroids, monoclonal antibody therapies, immunomodulators, and surgery.

• #51 Treat to target in Crohn’s disease: A practical guide for clinicians

  https://www.wjgnet.com/1007-9327/full/v30/i1/50.htm

  A treat-to-target (T2T) approach applies the principles of early intervention and tight disease control to optimise long-term outcomes in Crohn’s disease. […] Scheduled appraisal of Crohns disease activity against pre-defined treatment targets at these timepoints remains central to determining whether current therapy should be continued or modified. […] Consensus treatment targets in Crohns disease comprise combination clinical and patient-reported outcome remission, in conjunction with biomarker normalisation and endoscopic healing. […] Although the STRIDE-II guidelines endorse the pursuit of endoscopic healing, clinicians must consider that this may not always be appropriate, acceptable, or achievable in all patients. […] This underscores the need to engage patients at the outset in an effort to personalise care and individualise treatment targets.

• #52 Treat to target in Crohn’s disease: A practical guide for clinicians

  https://www.wjgnet.com/1007-9327/full/v30/i1/50.htm

  A treat-to-target (T2T) approach applies the principles of early intervention and tight disease control to optimise long-term outcomes in Crohn’s disease. […] Scheduled appraisal of Crohns disease activity against pre-defined treatment targets at these timepoints remains central to determining whether current therapy should be continued or modified. […] Consensus treatment targets in Crohns disease comprise combination clinical and patient-reported outcome remission, in conjunction with biomarker normalisation and endoscopic healing. […] Although the STRIDE-II guidelines endorse the pursuit of endoscopic healing, clinicians must consider that this may not always be appropriate, acceptable, or achievable in all patients. […] This underscores the need to engage patients at the outset in an effort to personalise care and individualise treatment targets.

Zobacz więcej